Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL.

Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.

2.

Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.

Sader HS, Jones RN, Silva JB; SENTRY Participants Group (Latin America).

Diagn Microbiol Infect Dis. 2002 Nov;44(3):281-8.

PMID:
12493176
4.
5.

Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.

Chinese XDR Consensus Working Group, Guan X, He L, Hu B, Hu J, Huang X, Lai G, Li Y, Liu Y, Ni Y, Qiu H, Shao Z, Shi Y, Wang M, Wang R, Wu D, Xie C, Xu Y, Yang F, Yu K, Yu Y, Zhang J, Zhuo C.

Clin Microbiol Infect. 2016 Mar;22 Suppl 1:S15-25. doi: 10.1016/j.cmi.2015.11.004. Epub 2015 Nov 25.

6.

[Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].

Acuner IC, Bayramoğlu G, Birinci A, Cekiç Cihan C, Bek Y, Durupınar B.

Mikrobiyol Bul. 2011 Jul;45(3):411-21. Turkish.

PMID:
21935774
8.
9.

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.

Falagas ME, Koletsi PK, Bliziotis IA.

J Med Microbiol. 2006 Dec;55(Pt 12):1619-29. Review.

PMID:
17108263
10.

Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).

Mendes RE, Sader HS, Jones RN.

Int J Antimicrob Agents. 2010 Oct;36(4):374-9. doi: 10.1016/j.ijantimicag.2010.05.016. Epub 2010 Jul 3.

PMID:
20598860
11.

Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.

Giani T, Morosini MI, D'Andrea MM, García-Castillo M, Rossolini GM, Cantón R.

Clin Microbiol Infect. 2012 Nov;18(11):E452-8. doi: 10.1111/j.1469-0691.2012.03980.x. Epub 2012 Aug 22.

13.

[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].

Eser OK, Ergin A, Hasçelik G.

Mikrobiyol Bul. 2009 Jul;43(3):383-90. Turkish.

PMID:
19795613
14.

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).

Mathai D, Lewis MT, Kugler KC, Pfaller MA, Jones RN; SENTRY Participants Group (North America).

Diagn Microbiol Infect Dis. 2001 Feb;39(2):105-16. Erratum in: Diagn Microbiol Infect Dis 2001 Apr;39(4):275.

PMID:
11248523
15.

Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.

Shokri D, Zaghian S, Khodabakhsh F, Fazeli H, Mobasherizadeh S, Ataei B.

J Microbiol Immunol Infect. 2014 Oct;47(5):371-6. doi: 10.1016/j.jmii.2013.05.004. Epub 2013 Jul 6.

16.

Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.

Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G.

Int J Antimicrob Agents. 2010 Mar;35(3):240-3. doi: 10.1016/j.ijantimicag.2009.10.019.

PMID:
20034765
17.

Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).

Ishii Y, Tateda K, Yamaguchi K; Japan Antimicrobial Resistance Surveillance Participants Group (JARS).

Diagn Microbiol Infect Dis. 2008 Feb;60(2):177-83. Epub 2007 Oct 10.

PMID:
17931820
18.

[Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories].

Koibuchi H, Shibuya Y, Kubo N, Kawano M, Itoh K.

Rinsho Byori. 2002 Oct;50(10):992-9. Japanese.

PMID:
12451681

Supplemental Content

Support Center